封面
市场调查报告书
商品编码
1678757

大肠直肠筛检市场规模、份额、趋势分析报告:按类型、产品、最终用途、地区和细分市场进行预测,2025 年至 2030 年

Colon Screening Market Size, Share & Trends Analysis Report By Type (Test, Product), By Product (Colonoscopes, Sigmoidoscopes, CT Scanners, MRI), By End-use, By Region, And Segment Forecasts, 2025 - 2030

出版日期: | 出版商: Grand View Research | 英文 150 Pages | 商品交期: 2-10个工作天内

价格

大肠直肠筛检市场的成长和趋势

根据Grand View Research, Inc.的最新报告,全球大肠直肠筛检市场规模预计到2030年将达到222.1亿美元,2025-2030年期间的复合年增长率为4.39%。

大肠直肠癌盛行率的不断上升、政府鼓励癌症筛检的倡议的不断增加以及市场技术的不断进步是推动市场成长的主要因素。根据CDC 2024年6月发布的资料,美国IBD的患病人数估计在240万至310万人之间。同样,预计到 2023 年全球溃疡性大肠炎患病人数将达到 500 万人。

大肠直肠筛检领域技术先进的产品的开发对市场成长做出了重大贡献。这些技术创新提高了诊断的准确性,改善了患者的舒适度,最大限度地降低了与传统程序相关的风险,并能够更早发现结肠相关疾病,包括癌症和息肉。例如,2024年5月,富士软片推出了两项创新的内视镜成像技术-CAD EYE和SCALE EYE。 CAD EYE 是一种人工智慧系统,旨在增强大肠镜检查期间对息肉和腺瘤等结直肠黏膜病变的检测。

此外,全球私营和公共参与企业不断努力提高人们对大肠直肠筛检的认识和可近性,进一步推动了各个地区的市场发展。例如,2024年11月,关岛地区医疗城引进了由美国农业部农村发展计画津贴的先进胶囊内视镜服务。这种创新的微创诊断解决方案是关岛及週边地区胃肠道医疗保健的重大进步,在推动医疗技术进步的同时,也优先考虑患者的舒适度。这些发展将增加获得先进诊断服务的机会并推动市场发展。

此外,广泛的定期筛检计画对于发现癌症和癌前息肉起着有效的作用。此外,包括人工智慧辅助检测在内的大肠镜技术的进步正在提高诊断效率和患者的治疗效果。例如,2023 年 12 月,Medtronic扩大了与 Cosmo Pharmaceuticals 的人工智慧合作,后者是一家插件软体开发商,其产品旨在在内视镜检查期间自动检测健康问题。

市场的主要企业正在致力于技术进步、新产品推出以及合作伙伴关係,以占领更高的市场占有率。例如,2022年2月,美敦力与美国胃肠内视镜学会(ASGE)合作,将其基于AI的大肠镜检查技术列入美国不足地区的大肠癌筛检名单。

大肠直肠筛检市场报告重点

  • 按类型划分,检查部分在 2024 年占据了市场的最大收益占有率。对简单和非侵入性筛检方法的不断增长的需求正在推动这一领域的成长。
  • 根据最终用途,由于结肠癌住院人数的增加和癌症筛检的采用率的提高,医院部门预计将在 2024 年占据市场的最大收益占有率。
  • 由于众多主要市场参与企业的存在和先进技术的高采用率,北美在 2024 年占据全球市场主导地位,收入份额为 51.3%。

目录

第一章调查方法与范围

第 2 章执行摘要

3. 大肠直肠筛检市场变数、趋势和范围

  • 市场体系展望
    • 母市场展望
    • 补贴市场前景
  • 市场动态
    • 市场驱动因素分析
    • 市场限制因素分析
  • 大肠直肠筛检:市场分析工具
    • 产业分析 – 波特五力分析
    • PESTLE分析
  • 2018 年至 2024 年大肠直肠筛检市场测试量
  • 大肠直肠检查产品市场价格分析

4. 2018 年至 2030 年大肠直肠筛检市场区隔分析(按类型)

  • 定义和范围
  • 2024 年及 2030 年各类型市场占有率分析
  • 细分仪表板
  • 2018 年至 2030 年全球大肠直肠筛检市场(按类型)
  • 检查
    • 2018-2030年测试市场收益估算及预测
    • 大肠镜检查
    • 胶囊内视镜
    • 影像检查
    • 其他的
    • 依最终用途和检验
  • 产品
    • 2018 年至 2030 年产品市场收益估计与预测
    • 大肠镜检查
    • 乙状结肠镜
    • CT 扫描仪
    • 磁振造影(MRI)
    • 按最终用途和产品

5. 2018 年至 2030 年大肠直肠筛检市场区隔分析(按地区)

  • 2024 年及 2030 年区域市场占有率分析
  • 区域市场仪表板
  • 区域市场概况
  • 2024 年及 2030 年各地区大肠直肠筛检市场占有率
  • 北美洲
    • 北美洲
    • 美国
    • 加拿大
    • 墨西哥
  • 欧洲
    • 欧洲
    • 英国
    • 德国
    • 法国
    • 义大利
    • 西班牙
    • 挪威
    • 瑞典
    • 丹麦
  • 亚太地区
    • 日本
    • 中国
    • 印度
    • 澳洲
    • 韩国
    • 泰国
  • 拉丁美洲
    • 巴西
    • 阿根廷
  • 中东和非洲
    • 南非
    • 沙乌地阿拉伯
    • 阿拉伯聯合大公国
    • 科威特

第六章竞争格局

  • 主要市场参与企业的近期趋势和影响分析
  • 公司分类
  • 公司简介
    • Olympus Corporation
    • PENTAX Medical(Hoya Corporation)
    • FUJIFILM Holdings Corporation
    • Medtronic
    • Ambu A/S
    • Baxter(Hillrom & Welch Allyn)
    • EndoFresh(Daichuan medical)
    • Bracco
    • Varay Laborix
Product Code: GVR-4-68040-523-1

Colon Screening Market Growth & Trends:

The global colon screening market size is expected to reach USD 22.21 billion by 2030, registering a CAGR of 4.39% from 2025 to 2030, according to a new report by Grand View Research, Inc. The growing prevalence of colorectal cancer, increasing government initiatives to encourage cancer screening, and ongoing technological advancements in the market are major factors driving the market growth. According to CDC data published in June 2024, the prevalence of IBD in the U.S. is estimated between 2.4 and 3.1 million. Similarly, the worldwide prevalence of ulcerative colitis was expected to be 5 million in 2023.

The development of technologically advanced products in colon screening has significantly contributed to the market's growth. These innovations have enhanced diagnostic accuracy, improved patient comfort, minimized risks associated with traditional procedures, and enabled earlier detection of colon-related diseases, including cancer and polyps. For instance, in May 2024, FUJIFILM launched two innovative endoscopic imaging technologies: CAD EYE and SCALE EYE. CAD EYE is an AI-powered system designed to enhance the detection of colonic mucosal lesions such as polyps and adenomas during colonoscopy.

In addition, the increasing efforts by private and public players worldwide to increase awareness and accessibility of colon screening have further driven the market across different regions. For instance, in November 2024, Guam Regional Medical City introduced an advanced capsule endoscopy service funded by a grant from the USDA Rural Development Program. This innovative, minimally invasive diagnostic solution represents a significant advancement in gastrointestinal healthcare for Guam and the surrounding region, enhancing medical technology while prioritizing patient comfort. Such developments increase access to advanced diagnosis services, thus driving market growth.

Moreover, the widespread adoption of routine screening programs has an effective role in detecting cancers & precancerous polyps. In addition, advancements in colonoscopy technology, including AI-assisted detection, have improved diagnostic efficiency and patient outcomes. For instance, in December 2023, Medtronic expanded its artificial intelligence collaboration with Cosmo Pharmaceuticals, the developer of plug-in software designed to detect health issues during endoscopic examinations automatically.

Key players in the market are engaged in technological advancements, new product launches, and partnerships & collaborations to gain a higher market share. For instance, in February 2022, Medtronic collaborated with the American Society for Gastrointestinal Endoscopy (ASGE) to offer AI-powered colonoscopy technology for colorectal cancer screening in underserved communities of the U.S.

Colon Screening Market Report Highlights:

  • Based on type, the test segment held the largest revenue share in the market in 2024. Rising demand for simple and non-invasive screening procedures is propelling the segment growth.
  • Based on end use, the hospital segment held the largest revenue share in the market in 2024, owing to the growing number of hospital admissions due to colon cancer and the rise in the adoption of cancer screening.
  • North America dominated the global market with a revenue share of 51.3% in 2024 due to the presence of a large number of major market players and the high adoption of advanced technologies.

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation & Scope
    • 1.1.1. Segment scope
    • 1.1.2. Regional scope
    • 1.1.3. Estimates and forecast timeline
  • 1.2. Research Methodology
  • 1.3. Information Procurement
    • 1.3.1. Purchased database
    • 1.3.2. GVR's internal database
    • 1.3.3. Secondary sources
    • 1.3.4. Primary research
    • 1.3.5. Details of primary research
  • 1.4. Information or Data Analysis
    • 1.4.1. Data analysis models
  • 1.5. Market Formulation & Validation
  • 1.6. Model Details
    • 1.6.1. Commodity flow analysis (Model 1)
      • 1.6.1.1. Approach 1: Commodity flow approach
  • 1.7. Research Assumptions
  • 1.8. List of Secondary Sources
  • 1.9. List of Primary Sources

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
    • 2.2.1. Type outlook
    • 2.2.2. Product outlook
    • 2.2.3. Regional outlook
  • 2.3. Competitive Insights

Chapter 3. Colon Screening Market Variables, Trends & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent market outlook
    • 3.1.2. Ancillary market outlook
  • 3.2. Market Dynamics
    • 3.2.1. Market driver analysis
      • 3.2.1.1. Rising prevalence of colorectal diseases
      • 3.2.1.2. Favorable government initiatives and reimbursement policies
      • 3.2.1.3. Introduction of technologically advanced products
    • 3.2.2. Market restraint analysis
      • 3.2.2.1. Stringent regulations
  • 3.3. Colon Screening: Market Analysis Tools
    • 3.3.1. Industry Analysis - Porter's
      • 3.3.1.1. Supplier Power
      • 3.3.1.2. Buyer Power
      • 3.3.1.3. Substitution Threat
      • 3.3.1.4. Threat of New Entrants
      • 3.3.1.5. Competitive Rivalry
    • 3.3.2. PESTLE Analysis
      • 3.3.2.1. Political landscape
      • 3.3.2.2. Economic Landscape
      • 3.3.2.3. Social Landscape
      • 3.3.2.4. Technological landscape
      • 3.3.2.5. Legal Landscape
      • 3.3.2.6. Environmental Landscape
  • 3.4. Colon Screening Market Number of Procedures, 2018 - 2024
  • 3.5. Colon Screening Market Pricing Analysis by Product

Chapter 4. Colon Screening Market Segment Analysis, By Type, 2018 - 2030 (USD Million)

  • 4.1. Definition and Scope
  • 4.2. Type Market Share Analysis, 2024 & 2030
  • 4.3. Segment Dashboard
  • 4.4. Global Colon Screening Market, by Type, 2018 to 2030
  • 4.5. Test
    • 4.5.1. Test Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 4.5.2. Colonoscopy
      • 4.5.2.1. Colonoscopy Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 4.5.3. Capsule Endoscopy
      • 4.5.3.1. Capsule Endoscopy Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 4.5.4. Imaging Tests
      • 4.5.4.1. Imaging Tests Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
      • 4.5.4.2. Virtual Colonoscopy
        • 4.5.4.2.1. Virtual Colonoscopy Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
      • 4.5.4.3. Magnetic resonance colonography (MRC)
        • 4.5.4.3.1. Magnetic resonance colonography (MRC) Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 4.5.5. Others
      • 4.5.5.1. Others Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 4.5.6. End Use, By Test
      • 4.5.6.1. Hospitals
        • 4.5.6.1.1. Hospitals Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
      • 4.5.6.2. Outpatient Facilities
        • 4.5.6.2.1. Outpatient Facilities Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 4.6. Product
    • 4.6.1. Product Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 4.6.2. Colonoscopes
      • 4.6.2.1. Colonoscopes Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 4.6.3. Sigmoidoscopes
      • 4.6.3.1. Sigmoidoscopes Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 4.6.4. CT Scanners
      • 4.6.4.1. CT Scanners Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 4.6.5. Magnetic Resonance Imaging (MRI)
      • 4.6.5.1. Magnetic Resonance Imaging (MRI) Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 4.6.6. End Use, By Product
      • 4.6.6.1. Hospitals
        • 4.6.6.1.1. Hospitals Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
      • 4.6.6.2. Outpatient Facilities
        • 4.6.6.2.1. Outpatient Facilities Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 5. Colon Screening Market Segment Analysis, By Region, 2018 - 2030 (USD Million)

  • 5.1. Regional Market Share Analysis, 2024 & 2030
  • 5.2. Regional Market Dashboard
  • 5.3. Regional Market Snapshot
  • 5.4. Colon Screening Market Share by Region, 2024 & 2030:
  • 5.5. North America
    • 5.5.1. North America colon screening market, 2018 - 2030 (USD Million)
    • 5.5.2. U.S.
      • 5.5.2.1. Key country dynamics
      • 5.5.2.2. Regulatory framework
      • 5.5.2.3. Competitive scenario
      • 5.5.2.4. U.S. colon screening market, 2018 - 2030 (USD Million)
    • 5.5.3. Canada
      • 5.5.3.1. Key country dynamics
      • 5.5.3.2. Regulatory framework
      • 5.5.3.3. Competitive scenario
      • 5.5.3.4. Canada colon screening market, 2018 - 2030 (USD Million)
    • 5.5.4. Mexico
      • 5.5.4.1. Key country dynamics
      • 5.5.4.2. Regulatory framework
      • 5.5.4.3. Competitive scenario
      • 5.5.4.4. Mexico colon screening market, 2018 - 2030 (USD Million)
  • 5.6. Europe
    • 5.6.1. Europe colon screening market, 2018 - 2030 (USD Million)
    • 5.6.2. UK
      • 5.6.2.1. Key country dynamics
      • 5.6.2.2. Regulatory framework
      • 5.6.2.3. Competitive scenario
      • 5.6.2.4. UK colon screening market, 2018 - 2030 (USD Million)
    • 5.6.3. Germany
      • 5.6.3.1. Key country dynamics
      • 5.6.3.2. Regulatory framework
      • 5.6.3.3. Competitive scenario
      • 5.6.3.4. Germany colon screening market, 2018 - 2030 (USD Million)
    • 5.6.4. France
      • 5.6.4.1. Key country dynamics
      • 5.6.4.2. Regulatory framework
      • 5.6.4.3. Competitive scenario
      • 5.6.4.4. France colon screening market, 2018 - 2030 (USD Million)
    • 5.6.5. Italy
      • 5.6.5.1. Key country dynamics
      • 5.6.5.2. Regulatory framework
      • 5.6.5.3. Competitive scenario
      • 5.6.5.4. Italy colon screening market, 2018 - 2030 (USD Million)
    • 5.6.6. Spain
      • 5.6.6.1. Key country dynamics
      • 5.6.6.2. Regulatory framework
      • 5.6.6.3. Competitive scenario
      • 5.6.6.4. Spain colon screening market, 2018 - 2030 (USD Million)
    • 5.6.7. Norway
      • 5.6.7.1. Key country dynamics
      • 5.6.7.2. Regulatory framework
      • 5.6.7.3. Competitive scenario
      • 5.6.7.4. Norway colon screening market, 2018 - 2030 (USD Million)
    • 5.6.8. Sweden
      • 5.6.8.1. Key country dynamics
      • 5.6.8.2. Regulatory framework
      • 5.6.8.3. Competitive scenario
      • 5.6.8.4. Sweden colon screening market, 2018 - 2030 (USD Million)
    • 5.6.9. Denmark
      • 5.6.9.1. Key country dynamics
      • 5.6.9.2. Regulatory framework
      • 5.6.9.3. Competitive scenario
      • 5.6.9.4. Denmark colon screening market, 2018 - 2030 (USD Million)
  • 5.7. Asia Pacific
    • 5.7.1. Japan
      • 5.7.1.1. Key country dynamics
      • 5.7.1.2. Regulatory framework
      • 5.7.1.3. Competitive scenario
      • 5.7.1.4. Japan colon screening market, 2018 - 2030 (USD Million)
    • 5.7.2. China
      • 5.7.2.1. Key country dynamics
      • 5.7.2.2. Regulatory framework
      • 5.7.2.3. Competitive scenario
      • 5.7.2.4. China colon screening market, 2018 - 2030 (USD Million)
    • 5.7.3. India
      • 5.7.3.1. Key country dynamics
      • 5.7.3.2. Regulatory framework
      • 5.7.3.3. Competitive scenario
      • 5.7.3.4. India colon screening market, 2018 - 2030 (USD Million)
    • 5.7.4. Australia
      • 5.7.4.1. Key country dynamics
      • 5.7.4.2. Regulatory framework
      • 5.7.4.3. Competitive scenario
      • 5.7.4.4. Australia colon screening market, 2018 - 2030 (USD Million)
    • 5.7.5. South Korea
      • 5.7.5.1. Key country dynamics
      • 5.7.5.2. Regulatory framework
      • 5.7.5.3. Competitive scenario
      • 5.7.5.4. South Korea colon screening market, 2018 - 2030 (USD Million)
    • 5.7.6. Thailand
      • 5.7.6.1. Key country dynamics
      • 5.7.6.2. Regulatory framework
      • 5.7.6.3. Competitive scenario
      • 5.7.6.4. Thailand colon screening market, 2018 - 2030 (USD Million)
  • 5.8. Latin America
    • 5.8.1. Brazil
      • 5.8.1.1. Key country dynamics
      • 5.8.1.2. Regulatory framework
      • 5.8.1.3. Competitive scenario
      • 5.8.1.4. Brazil colon screening market, 2018 - 2030 (USD Million)
    • 5.8.2. Argentina
      • 5.8.2.1. Key country dynamics
      • 5.8.2.2. Regulatory framework
      • 5.8.2.3. Competitive scenario
      • 5.8.2.4. Argentina colon screening market, 2018 - 2030 (USD Million)
  • 5.9. MEA
    • 5.9.1. South Africa
      • 5.9.1.1. Key country dynamics
      • 5.9.1.2. Regulatory framework
      • 5.9.1.3. Competitive scenario
      • 5.9.1.4. South Africa colon screening market, 2018 - 2030 (USD Million)
    • 5.9.2. Saudi Arabia
      • 5.9.2.1. Key country dynamics
      • 5.9.2.2. Regulatory framework
      • 5.9.2.3. Competitive scenario
      • 5.9.2.4. Saudi Arabia colon screening market, 2018 - 2030 (USD Million)
    • 5.9.3. UAE
      • 5.9.3.1. Key country dynamics
      • 5.9.3.2. Regulatory framework
      • 5.9.3.3. Competitive scenario
      • 5.9.3.4. UAE colon screening market, 2018 - 2030 (USD Million)
    • 5.9.4. Kuwait
      • 5.9.4.1. Key country dynamics
      • 5.9.4.2. Regulatory framework
      • 5.9.4.3. Competitive scenario
      • 5.9.4.4. Kuwait colon screening market, 2018 - 2030 (USD Million)

Chapter 6. Competitive Landscape

  • 6.1. Recent Developments & Impact Analysis, By Key Market Participants
  • 6.2. Company Categorization
  • 6.3. Company Profiles
    • 6.3.1. Olympus Corporation
      • 6.3.1.1. Company overview
      • 6.3.1.2. Financial performance
      • 6.3.1.3. Platform benchmarking
      • 6.3.1.4. Strategic initiatives
    • 6.3.2. PENTAX Medical (Hoya Corporation)
      • 6.3.2.1. Company overview
      • 6.3.2.2. Financial performance
      • 6.3.2.3. Platform benchmarking
      • 6.3.2.4. Strategic initiatives
    • 6.3.3. FUJIFILM Holdings Corporation
      • 6.3.3.1. Company overview
      • 6.3.3.2. Financial performance
      • 6.3.3.3. Platform benchmarking
      • 6.3.3.4. Strategic initiatives
    • 6.3.4. Medtronic
      • 6.3.4.1. Company overview
      • 6.3.4.2. Financial performance
      • 6.3.4.3. Platform benchmarking
      • 6.3.4.4. Strategic initiatives
    • 6.3.5. Ambu A/S
      • 6.3.5.1. Company overview
      • 6.3.5.2. Financial performance
      • 6.3.5.3. Platform benchmarking
      • 6.3.5.4. Strategic initiatives
    • 6.3.6. Baxter (Hillrom & Welch Allyn)
      • 6.3.6.1. Company overview
      • 6.3.6.2. Financial performance
      • 6.3.6.3. Platform benchmarking
      • 6.3.6.4. Strategic initiatives
    • 6.3.7. EndoFresh (Daichuan medical)
      • 6.3.7.1. Company overview
      • 6.3.7.2. Financial performance
      • 6.3.7.3. Platform benchmarking
      • 6.3.7.4. Strategic initiatives
    • 6.3.8. Bracco
      • 6.3.8.1. Company overview
      • 6.3.8.2. Financial performance
      • 6.3.8.3. Platform benchmarking
      • 6.3.8.4. Strategic initiatives
    • 6.3.9. Varay Laborix
      • 6.3.9.1. Company overview
      • 6.3.9.2. Financial performance
      • 6.3.9.3. Platform benchmarking
      • 6.3.9.4. Strategic initiatives

List of Tables

  • Table 1 List of secondary sources
  • Table 2 List of abbreviations
  • Table 3 Global Colon Screening Market, By Type, 2018 - 2030 (USD Million)
  • Table 4 Global Colon Screening Market, By Region, 2018 - 2030 (USD Million)
  • Table 5 North America Colon Screening Market, By Country, 2018 - 2030 (USD Million)
  • Table 6 North America Colon Screening Market, By Type, 2018 - 2030 (USD Million)
  • Table 7 U.S. Colon Screening Market, by Type, 2018 - 2030 (USD Million)
  • Table 8 Canada Colon Screening Market, by Type, 2018 - 2030 (USD Million)
  • Table 9 Mexico Colon Screening Market, by Type, 2018 - 2030 (USD Million)
  • Table 10 Europe Colon Screening Market, by Country, 2018 - 2030 (USD Million)
  • Table 11 Europe Colon Screening Market, By End Use, 2018 - 2030 (USD Million)
  • Table 12 UK. Colon Screening Market, by Type, 2018 - 2030 (USD Million)
  • Table 13 Germany Colon Screening Market, by Type, 2018 - 2030 (USD Million)
  • Table 14 France Colon Screening Market, by Type, 2018 - 2030 (USD Million)
  • Table 15 Italy Colon Screening Market, by Type, 2018 - 2030 (USD Million)
  • Table 16 Spain Colon Screening Market, by Type, 2018 - 2030 (USD Million)
  • Table 17 Denmark Colon Screening Market, by Type, 2018 - 2030 (USD Million)
  • Table 18 Sweden Colon Screening Market, by Type, 2018 - 2030 (USD Million)
  • Table 19 Norway Colon Screening Market, by Type, 2018 - 2030 (USD Million)
  • Table 20 Asia Pacific Colon Screening Market, by Country, 2018 - 2030 (USD Million)
  • Table 21 Asia Pacific Colon Screening Market, by Type, 2018 - 2030 (USD Million)
  • Table 22 Japan Colon Screening Market, by Type, 2018 - 2030 (USD Million)
  • Table 23 China Colon Screening Market, by Type, 2018 - 2030 (USD Million)
  • Table 24 India Colon Screening Market, By End Use, 2018 - 2030 (USD Million)
  • Table 25 Australia Colon Screening Market, by Type, 2018 - 2030 (USD Million)
  • Table 26 Thailand Colon Screening Market, by Type, 2018 - 2030 (USD Million)
  • Table 27 South Korea Colon Screening Market, by Type, 2018 - 2030 (USD Million)
  • Table 28 Latin America Colon Screening Market, by Country, 2018 - 2030 (USD Million)
  • Table 29 Latin America Colon Screening Market, by Type, 2018 - 2030 (USD Million)
  • Table 30 Brazil Colon Screening Market, by Type, 2018 - 2030 (USD Million)
  • Table 31 Argentina Colon Screening Market, by Type, 2018 - 2030 (USD Million)
  • Table 32 Middle East & Africa Colon Screening Market, by Country, 2018 - 2030 (USD Million)
  • Table 33 Middle East & Africa Colon Screening Market, by Type, 2018 - 2030 (USD Million)
  • Table 34 South Africa Colon Screening Market, by Type, 2018 - 2030 (USD Million)
  • Table 35 Saudi Arabia Colon Screening Market, by Type, 2018 - 2030 (USD Million)
  • Table 36 UAE Colon Screening Market, by Type, 2018 - 2030 (USD Million)
  • Table 37 Kuwait Colon Screening Market, by Type, 2018 - 2030 (USD Million)

List of Figures

  • Fig. 1 Market research process
  • Fig. 2 Data triangulation techniques
  • Fig. 3 Primary research pattern
  • Fig. 4 Market research approaches
  • Fig. 5 Value-chain-based sizing & forecasting
  • Fig. 6 QFD modeling for market share assessment
  • Fig. 7 Market formulation & validation
  • Fig. 8 Colon Screening market: outlook
  • Fig. 9 Colon Screening competitive insights
  • Fig. 10 Ancillary market outlook
  • Fig. 11 Colon Screening market driver impact
  • Fig. 12 Colon Screening market restraint impact
  • Fig. 13 Porter's Analysis
  • Fig. 14 PESTLE Analysis
  • Fig. 15 Colon Screening market: Type movement analysis
  • Fig. 16 Colon Screening market: Type outlook and key takeaways
  • Fig. 17 Test market estimates and forecast, 2018 - 2030
  • Fig. 18 Colonoscopy market estimates and forecast, 2018 - 2030
  • Fig. 19 Capsule Endoscopy market estimates and forecast, 2018 - 2030
  • Fig. 20 Imaging Tests market estimates and forecast, 2018 - 2030
  • Fig. 21 Virtual Colonoscopy market estimates and forecast, 2018 - 2030
  • Fig. 22 Magnetic resonance colonography (MRC) market estimates and forecast, 2018 - 2030
  • Fig. 23 Others market estimates and forecast, 2018 - 2030
  • Fig. 24 By Test, Hospitals market estimates and forecasts, 2018 - 2030
  • Fig. 25 By Test, Outpatient Facilities market estimates and forecasts,2018 - 2030
  • Fig. 26 Product market estimates and forecast, 2018 - 2030
  • Fig. 27 Colonoscopes market estimates and forecast, 2018 - 2030
  • Fig. 28 Sigmoidoscopes market estimates and forecast, 2018 - 2030
  • Fig. 29 CT Scanners market estimates and forecast, 2018 - 2030
  • Fig. 30 Magnetic Resonance Imaging (MRI) market estimates and forecast, 2018 - 2030
  • Fig. 31 By Product, Hospitals market estimates and forecasts, 2018 - 2030
  • Fig. 32 By Product, Outpatient Facilities market estimates and forecasts,2018 - 2030
  • Fig. 33 Global colon screening market: Regional movement analysis
  • Fig. 34 Global colon screening market: Regional outlook and key takeaways
  • Fig. 35 North America colon screening market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 36 Key country dynamics
  • Fig. 37 U.S. colon screening market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 38 Key country dynamics
  • Fig. 39 Canada colon screening market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 40 Key country dynamics
  • Fig. 41 Mexico colon screening market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 42 Europe colon screening market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 43 Key country dynamics
  • Fig. 44 UK colon screening market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 45 Key country dynamics
  • Fig. 46 Germany colon screening market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 47 Key country dynamics
  • Fig. 48 Spain colon screening market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 49 Key country dynamics
  • Fig. 50 France colon screening market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 51 Key country dynamics
  • Fig. 52 Italy colon screening market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 53 Key country dynamics
  • Fig. 54 Norway colon screening market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 55 Key country dynamics
  • Fig. 56 Denmark colon screening market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 57 Key country dynamics
  • Fig. 58 Sweden colon screening market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 59 Asia Pacific colon screening market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 60 Key country dynamics
  • Fig. 61 Japan colon screening market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 62 Key country dynamics
  • Fig. 63 China colon screening market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 64 Key country dynamics
  • Fig. 65 India colon screening market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 66 Key country dynamics
  • Fig. 67 Australia colon screening market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 68 Key country dynamics
  • Fig. 69 South Korea colon screening market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 70 Key country dynamics
  • Fig. 71 Thailand colon screening market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 72 Latin America colon screening market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 73 Key country dynamics
  • Fig. 74 Brazil colon screening market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 75 Key country dynamics
  • Fig. 76 Argentina colon screening market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 77 MEA colon screening market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 78 Key country dynamics
  • Fig. 79 South Africa colon screening market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 80 Key country dynamics
  • Fig. 81 Saudi Arabia colon screening market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 82 Key country dynamics
  • Fig. 83 UAE colon screening market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 84 Key country dynamics
  • Fig. 85 Kuwait colon screening market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 86 Key company categorization
  • Fig. 87 Heat map analysis 2024